Gut microbes may flag early memory decline, small study finds

A stool sample, a machine-learning model and a year of memory tests: that is the chain of steps behind a study that may one day help doctors recognise early memory problems. Researchers from Cardiff University and Imperial College London examined 35 older adults, most of them living with a partner. In each couple, one person had mild cognitive impairment and the other did not. The team looked at both the gut bacteria and the chemicals those bacteria produce, a combination that the researchers believe has not been studied this way before.

The results show a clear difference. People with mild cognitive impairment had significantly elevated levels of the bacteria Izemoplasmatales and of the gut chemical proline. They also had lower levels of Ruminococcus and Lachnospira bacteria and of fumaric acid. These bacteria belong to a larger group already linked to brain health in earlier studies. The team then tested the same markers on an independent group from a previous study, and they still separated people with mild cognitive impairment from healthy individuals. According to the researchers, a combination of bacteria and chemicals distinguished the two groups with high accuracy.

The second finding concerns the future. Over a year of follow-up, people with mild cognitive impairment whose starting samples held more Bilophila and certain chemicals (arginine, aspartic acid and hypoxanthine), and less Coprococcus, showed a faster decline in memory and thinking skills. For a patient, this would mean that a sample taken today could indicate who is more likely to get worse quickly, which is precisely the question clinicians currently struggle to answer.

The limits are considerable, and the authors state them plainly. The study involved only 35 people, so the markers are not yet a diagnostic tool. The researchers say further work is needed in more diverse groups, and they want to examine the influence of diet, lifestyle, ethnicity, environment and genetic risk. Julian Marchesi of Imperial College London said that future studies on larger groups will help identify which microbes and chemicals matter most.

What would change if these markers hold up? In principle, people at risk could be identified through simple, non-invasive tests, and earlier diagnosis could follow. But that step depends on larger studies that do not yet exist, and no timeline has been announced. For now, the research gives a new direction: the gut may offer an early view of what is happening in the brain.